276 related articles for article (PubMed ID: 30733317)
1. Preclinical Evaluation and Nonhuman Primate Receptor Occupancy Study of
Kolb HC; Barret O; Bhattacharya A; Chen G; Constantinescu C; Huang C; Letavic M; Tamagnan G; Xia CA; Zhang W; Szardenings AK
J Nucl Med; 2019 Aug; 60(8):1154-1159. PubMed ID: 30733317
[TBL] [Abstract][Full Text] [Related]
2. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
3. PET Imaging of the P2X7 Ion Channel with a Novel Tracer [
Berdyyeva T; Xia C; Taylor N; He Y; Chen G; Huang C; Zhang W; Kolb H; Letavic M; Bhattacharya A; Szardenings AK
Mol Imaging Biol; 2019 Oct; 21(5):871-878. PubMed ID: 30632003
[TBL] [Abstract][Full Text] [Related]
4.
Koole M; Schmidt ME; Hijzen A; Ravenstijn P; Vandermeulen C; Van Weehaeghe D; Serdons K; Celen S; Bormans G; Ceusters M; Zhang W; Van Nueten L; Kolb H; de Hoon J; Van Laere K
J Nucl Med; 2019 May; 60(5):683-690. PubMed ID: 30262518
[TBL] [Abstract][Full Text] [Related]
5. Pharmacological characterization of a novel centrally permeable P2X7 receptor antagonist: JNJ-47965567.
Bhattacharya A; Wang Q; Ao H; Shoblock JR; Lord B; Aluisio L; Fraser I; Nepomuceno D; Neff RA; Welty N; Lovenberg TW; Bonaventure P; Wickenden AD; Letavic MA
Br J Pharmacol; 2013 Oct; 170(3):624-40. PubMed ID: 23889535
[TBL] [Abstract][Full Text] [Related]
6. A novel radioligand for the ATP-gated ion channel P2X7: [3H] JNJ-54232334.
Lord B; Ameriks MK; Wang Q; Fourgeaud L; Vliegen M; Verluyten W; Haspeslagh P; Carruthers NI; Lovenberg TW; Bonaventure P; Letavic MA; Bhattacharya A
Eur J Pharmacol; 2015 Oct; 765():551-9. PubMed ID: 26386289
[TBL] [Abstract][Full Text] [Related]
7. Translational Model-Informed Dose Selection for a Human Positron Emission Tomography Imaging Study of JNJ-54175446, a P2X7 Receptor Antagonist.
Xu Y; Miao X; Ravenstijn P; Hijzen A; Schmidt ME; Nandy P; Zhou H
Clin Transl Sci; 2020 Mar; 13(2):309-317. PubMed ID: 31642608
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychopharmacology of JNJ-55308942: evaluation of a clinical candidate targeting P2X7 ion channels in animal models of neuroinflammation and anhedonia.
Bhattacharya A; Lord B; Grigoleit JS; He Y; Fraser I; Campbell SN; Taylor N; Aluisio L; O'Connor JC; Papp M; Chrovian C; Carruthers N; Lovenberg TW; Letavic MA
Neuropsychopharmacology; 2018 Dec; 43(13):2586-2596. PubMed ID: 30026598
[TBL] [Abstract][Full Text] [Related]
9. Pharmacology of a novel central nervous system-penetrant P2X7 antagonist JNJ-42253432.
Lord B; Aluisio L; Shoblock JR; Neff RA; Varlinskaya EI; Ceusters M; Lovenberg TW; Carruthers N; Bonaventure P; Letavic MA; Deak T; Drinkenburg W; Bhattacharya A
J Pharmacol Exp Ther; 2014 Dec; 351(3):628-41. PubMed ID: 25271258
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of
Nabulsi NB; Holden D; Zheng MQ; Bois F; Lin SF; Najafzadeh S; Gao H; Ropchan J; Lara-Jaime T; Labaree D; Shirali A; Slieker L; Jesudason C; Barth V; Navarro A; Kant N; Carson RE; Huang Y
J Nucl Med; 2019 Aug; 60(8):1147-1153. PubMed ID: 30733324
[TBL] [Abstract][Full Text] [Related]
11. What We Observe In Vivo Is Not Always What We See In Vitro: Development and Validation of 11C-JNJ-42491293, A Novel Radioligand for mGluR2.
Leurquin-Sterk G; Celen S; Van Laere K; Koole M; Bormans G; Langlois X; Van Hecken A; Te Riele P; Alcázar J; Verbruggen A; de Hoon J; Andrés JI; Schmidt ME
J Nucl Med; 2017 Jan; 58(1):110-116. PubMed ID: 27469358
[TBL] [Abstract][Full Text] [Related]
12. Minimally invasive quantification of cerebral P2X7R occupancy using dynamic [
Mertens N; Schmidt ME; Hijzen A; Van Weehaeghe D; Ravenstijn P; Depre M; de Hoon J; Van Laere K; Koole M
Sci Rep; 2021 Aug; 11(1):16172. PubMed ID: 34373571
[TBL] [Abstract][Full Text] [Related]
13. Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants.
Timmers M; Ravenstijn P; Xi L; Triana-Baltzer G; Furey M; Van Hemelryck S; Biewenga J; Ceusters M; Bhattacharya A; van den Boer M; van Nueten L; de Boer P
J Psychopharmacol; 2018 Dec; 32(12):1341-1350. PubMed ID: 30260294
[TBL] [Abstract][Full Text] [Related]
14. Characterization of the Novel P2X7 Receptor Radioligand [
Mikkelsen JD; Aripaka SS; Kaad S; Pazarlar BA; Pinborg L; Finsen B; Varrone A; Bang-Andersen B; Bastlund JF
ACS Chem Neurosci; 2023 Jan; 14(1):111-118. PubMed ID: 36535632
[TBL] [Abstract][Full Text] [Related]
15. Receptor localization, native tissue binding and ex vivo occupancy for centrally penetrant P2X7 antagonists in the rat.
Able SL; Fish RL; Bye H; Booth L; Logan YR; Nathaniel C; Hayter P; Katugampola SD
Br J Pharmacol; 2011 Jan; 162(2):405-14. PubMed ID: 20840537
[TBL] [Abstract][Full Text] [Related]
16. P2X7 PET Radioligand
Fu Z; Lin Q; Hu B; Zhang Y; Chen W; Zhu J; Zhao Y; Choi HS; Shi H; Cheng D
J Nucl Med; 2019 Jul; 60(7):930-936. PubMed ID: 30655332
[TBL] [Abstract][Full Text] [Related]
17. Increased uptake of the P2X7 receptor radiotracer
Morgan J; Moreno O; Alves M; Baz Z; Menéndez Méndez A; Leister H; Melia C; Smith J; Visekruna A; Nicke A; Bhattacharya A; Ceusters M; Henshall DC; Gómez-Vallejo V; Llop J; Engel T
Epilepsia; 2023 Feb; 64(2):511-523. PubMed ID: 36507708
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and Characterization of [
Yuan G; Guehl NJ; Zheng B; Qu X; Moon SH; Dhaynaut M; Shoup TM; Afshar S; Kang HJ; Zhang Z; El Fakhri G; Normandin MD; Brownell AL
Mol Imaging Biol; 2021 Aug; 23(4):527-536. PubMed ID: 33559035
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic characterizations of a P2X7 receptor-specific radioligand, [11C]GSK1482160 for neuroinflammatory response.
Han J; Liu H; Liu C; Jin H; Perlmutter JS; Egan TM; Tu Z
Nucl Med Commun; 2017 May; 38(5):372-382. PubMed ID: 28338530
[TBL] [Abstract][Full Text] [Related]
20. Radiosynthesis and initial characterization of a PDE10A specific PET tracer [18F]AMG 580 in non-human primates.
Hwang DR; Hu E; Allen JR; Davis C; Treanor J; Miller S; Chen H; Shi B; Narayanan TK; Barret O; Alagille D; Yu Z; Slifstein M
Nucl Med Biol; 2015 Aug; 42(8):654-63. PubMed ID: 25935386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
